FIELD: medicine.
SUBSTANCE: present invention relates to the field of medicine, namely oncology, and reveals the use of sodium salt 4-{2-[2-(4-hydroxy-3-methoxyphenyl)-vinyl]-6-ethyl-4-oxo-5-phenyl-4H-pyrimidine-1-yl}-benzosulfamide, of formula I, as a remedy with antitumor effect in melanoma.
EFFECT: pronounced cytostatic activity of the sodium salt 4-{2-[2-(4-hydroxy-3-methoxyphenyl)-vinyl]-6-ethyl-4-oxo-5-phenyl-4H-pyrimidine-1-yl}-benzosulfamide, of formula I, which has an antitumor effect in melanoma.
1 cl, 3 tbl
Формула I – Formula I
Authors
Dates
2022-01-11—Published
2021-03-26—Filed